| Soul Work Counseling, Llc | |
|
11925 Central Ave Ne Blaine MN 55434-3911 | |
| (763) 746-0842 | |
| (763) 208-7297 |
| Full Name | Soul Work Counseling, Llc |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 11925 Central Ave Ne, Blaine, Minnesota |
| Authorized Official Name and Position | Janet K Schlegel (OWNER) |
| Authorized Official Contact | 7637460842 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Soul Work Counseling, Llc 11925 Central Ave Ne Blaine MN 55434-3911 Ph: (763) 746-0842 | Soul Work Counseling, Llc 11925 Central Ave Ne Blaine MN 55434-3911 Ph: (763) 746-0842 |
| NPI Number | 1710295001 |
|---|---|
| Provider Enumeration Date | 09/20/2010 |
| Last Update Date | 07/21/2022 |
| Certification Date | 08/05/2021 |
| Medicare PECOS PAC ID | 4789910233 |
|---|---|
| Medicare Enrollment ID | O20190723000039 |
News Archive
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.
New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710295001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 1604 (Minnesota) | Primary |
| Provider Name | Shawna M Benson |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1447351812 PECOS PAC ID: 7517914252 Enrollment ID: I20050405000324 |
News Archive
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.
New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
› Verified 5 days ago
| Provider Name | Jennifer Lynn Lees |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1558430041 PECOS PAC ID: 2769412766 Enrollment ID: I20050819000047 |
News Archive
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.
New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
› Verified 5 days ago
| Provider Name | Cynthia White Meyer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1962619049 PECOS PAC ID: 3173624772 Enrollment ID: I20070726000565 |
News Archive
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.
New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
› Verified 5 days ago
| Provider Name | Terry Riley |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1154601243 PECOS PAC ID: 4385088004 Enrollment ID: I20240221000504 |
News Archive
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.
New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
› Verified 5 days ago
| Provider Name | Deborah Mueller |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1366981334 PECOS PAC ID: 5799120424 Enrollment ID: I20240304001880 |
News Archive
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.
New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
› Verified 5 days ago
News Archive
Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal
Patients with focal epilepsy that does not respond to medications badly need alternative treatments.
New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
› Verified 5 days ago
Adams Autism Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11070 Fergus St Ne Unit B, Blaine, MN 55449 Phone: 612-401-3484 | |
Beacon Mental Health Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 County Road 10 Ne Ste 200, Blaine, MN 55434 Phone: 320-364-0277 | |
Therapeutic Connections Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4255 Pheasant Ridge Dr Ne, 412, Blaine, MN 55449 Phone: 763-317-6222 Fax: 763-307-3835 | |
Promising Educational Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12216 3rd St Ne, Blaine, MN 55434 Phone: 952-297-9052 | |
Breanna Hoffman Therapeutic Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4255 Pheasant Ridge Dr Ne Ste 412, Blaine, MN 55449 Phone: 763-703-3755 | |
Lakes Housing Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13176 Coral Sea Ct Ne, Blaine, MN 55449 Phone: 612-547-8061 | |
Sense-ational Spaces, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11517 Polk St Ne, Blaine, MN 55434 Phone: 651-233-7436 |